Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Bone Diseases

• Akkermansia Muciniphilia and Metabolic Side Effects of ADT
• Effect of Dapagliflozin on Renal Outcomes and Bone Mineral Disease in Non-diabetic Chronic Kidney Disease Patients
• Neutrophil Gelatinase-associated Lipocalin VS Vascular Calcification in Maintenance Hemodialysis Patients
• PRevEnting FracturEs in Renal Disease - 1
• Injection of Teriparatide to Prevent Hypocalcemia After Parathyroidectomy in Dialysis Patients (TeriCa).
• A Clinical Trial to Evaluate the Bone Metabolism and the Blood Sugar of Evogliptin and Dapagliflozin
• Treatment of Adynamic Bone Disorder With Parathyroid Hormone in Chronic Kidney Disease
• The Effect of Etelcalcetide on CKD-MBD
• Pilot E2 for Hypogonadal Women With CFBD
• Denosumab Treatment for Fibrous Dysplasia
• Switch to Genvoya Followed by HCV Therapy With Epclusa Followed by Simplification of HIV Therapy With Biktarvy in Patients With HIV-HCV Co-Infected Subjects on Opioid Substitution Therapy
• The Association Between Hyponatremia and Osteoporosis in Patients With Epilepsy.
• The Effect of Diuretics on Mineral and Bone Disorder in Chronic Kidney Disease Patients
• Cholecalciferol Supplementation in Restless Leg Syndrome in Patients With Chronic Kidney Disease
• Effect of Vitamin D3 Supplementation on Arterial and Bone Remodeling in Chronic Kidney Disease Patients
• Evaluating Stereotactic Body Radiation Therapy for Oligometastatic Disease of the Bone
• Denosumab in Metabolic Bone Disease in Chronic Intestinal Failure Patients
• A Pilot Study of MSCs Iufusion and Etanercept to Treat Ankylosing Spondylitis
• Drug Penetration Into Bone After Repeated Oral Administration of Debio 1450 to Patients Undergoing Hip Replacement Surgery
• A Study to Evaluate Renal Safety of Intravenous Ibandronate (Bondronat) in Participants With Metastatic Bone Disease Due to Breast Cancer
• Clindamycin-rifampin Drug Interaction in the Treatment of Bone and Joint Infections
• A Study of Ibandronate (Bondronat) in Participants With Metastatic Bone Disease
• A Study of Ibandronate (Bondronat) in Participants With Malignant Bone Disease
• European Transplant Registry of Senior Renal Transplant Recipients on Advagraf
• Phase Ib Study of Radium Ra 223 Dichloride in Combination With Paclitaxel in Cancer Subjects With Bone Lesions
• Assessing the Impact of Contraceptives on Bone Health Using 41Ca
• Effects of Oral vs. Non-oral Contraceptives on the GH/IGF-1 Axis
• Prospective Biomarkers of Bone Metabolism in Hemophilia A
• Prolonged Protection From Bone Disease in Multiple Myeloma
• Lanthanum Versus Calcium Carbonate for Vascular Abnormalities in Patients With CKD and Hyperphosphatemia
• Evaluate Time Associated With the Preparation & Administration of Denosumab/Pamidronate in Patients With Solid Tumors and Metastatic Bone Disease
• Treatment of Atraumatic Bone Marrow Edema With Denosumab and Teriparatide vs Placebo
• Management of Mineral and Bone Disease in Hemodialysis-Calcitriol vs. Paricalcitol
• Parallel Study Between BMP-2 and Autologous Bone Graft After Ilizarow Treatment
• Effects of Zortress® + Tacrolimus vs. Standard Immunosuppression on Progression of Coronary Artery Calcifications and Bone Disease in de Novo Renal Transplant Recipients
• XL184 For Relapsed/Refractory Multiple Myeloma (MM) With Bone Disease
• Vitamin D Supplementation in Diabetic Nephropathy
• Drug Exposure and Depot Medroxyprogesterone Acetate (DMPA) in Adolescent Subjects
• Etelcalcetide to Treat Secondary Hyperparathyroidism in Hemodialysis Patients With Chronic Kidney Disease-Mineral and Bone Disorder
• Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Patients With Multiple Myeloma
• One Week Comparison Study of PTH and PTHrP Infusions
• Impact of Chemotherapy Followed by Aromatase Inhibitors on Bone Health of Women With ER-positive Early Breast Cancer
• Velcade Consolidation Bone Study
• The Effect of Lanthanum Carbonate on Fibroblast Growth Factor 23 ( FGF23) in Chronic Kidney Disease
• A Study to Evaluate Food Effect on ONO-5920/YM529 Intermittent Formulation
• Metabolic Acidosis in Renal Transplant Patients
• Ph I/II of Vitamin D on Bone Mineral Density & Markers of Bone Resorption
• Efficacy and Safety of Single Dose of 5 mg Zoledronic Acid in Chinese Patients With Paget's Disease of Bone (PDB)
• A Study to Assess BHQ880 in Combination With Zoledronic Acid in Relapsed or Refractory Myeloma Patients
• Re-treatment of Participants With Paget's Disease Using Zoledronic Acid
• Effects of rhIGF-1 on Bone Metabolism in Adolescent Girls With Anorexia Nervosa
• Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast®
• Efficacy of Pamidronate in the Treatment of Bone Loss Associated With Liver Transplant
• Bone Disease in Severely Burned Children
• Study to Evaluate the Safety and Effects AZD0530 on Prostate and Breast Cancer Subjects With Metastatic Bone Disease
• A Research Study to Test the Effectiveness of MK0217 in Patients With Paget's Bone Disease (0217-206)(COMPLETED)
• A Study to Examine the Effects of an Experimental Drug on Women With Breast Cancer and Metastatic Bone Disease (MBD)(0822-016)(COMPLETED)
• 7 Day Continuous Parathyroid Hormone IV Infusion
• The Effects of Potassium Citrate on Bone Metabolism
• 18F-Fluoride Positron Emission Tomography (PET) in Paget's Disease of Bone
• Pamidronate, Vitamin D, and Calcium for the Bone Disease of Kidney and Heart Transplantation
• MK0429 Study in Prostate Cancer Patients With Metastatic Bone Disease (0429-011)
• Study Comparing Full-dose Radiotherapy Versus Reduced Dose in the Management of Bone Metastasis in Patients With Breast Cancer Receiving Zoledronic Acid
• Bisphosphonate Therapy for Osteogenesis Imperfecta
• Study of Alendronate to Prevent and Treat Osteoporosis in Cystic Fibrosis Patients
• Safety and Efficacy Trial With Zoledronic Acid for the Treatment of Paget's Disease of Bone, Including an Extended Observation Period
• A Study to Assess the Efficacy of Intravenous Bondronat (Ibandronate) in Patients With Malignant and Painful Bone Disease
• A Study to Assess the Efficacy of Intravenous/Oral Bondronat (Ibandronate) in Patients With Metastatic Bone Disease Experiencing Moderate to Severe Pain
• Safety and Efficacy Trial With Zoledronic Acid for the Treatment of Paget's Disease of Bone, Including an Extended Observation Period
• CVD Risk and Health in Postmenopausal Phytoestrogen Users
• Women's Health Initiative (WHI)
• Postmenopausal Estrogen/Progestin Interventions (PEPI)